(Singapore, 22 August 2024)
BW LPG Limited ("BW LPG" or the "Company", OSE ticker code: "BWLPG.OL", NYSE
ticker code "BWLP") provides the following key information relating to the
Company's cash dividend for Q2 2024:
The Board has approved a dividend of US$0.58 on 21 August 2024. Dividends
payable to shares registered with Euronext VPS will be distributed in NOK, with
the exchange rate made available on the day of payment.
Record date: 10 September 2024
Shares registered with Euronext VPS Oslo Stock Exchange
===============================
Last trading day including the right to receive this dividend: 6 September 2024
Ex-date: 9 September 2024
Dividend payment date: On or about 30 September 2024
Shares registered with Depository Trust Company
===============================
Last trading day including the right to receive this dividend: 9 September 2024
Ex-date: 10 September 2024
Dividend payment date: On or about 25 September 2024
For further information, please contact:
Samantha Xu
Chief Financial Officer
E-mail: investor.relations@bwlpg.com
About BW LPG
BW LPG is the world's leading owner and operator of LPG vessels, owning and
operating Very Large Gas Carriers (VLGC) with a total carrying capacity of over
3 million CBM. With five decades of operating experience in LPG shipping, an
in-house LPG trading division and a growing presence in LPG terminal
infrastructure and distribution, BW LPG offers an integrated, flexible, and
reliable service to customers along the LPG value chain. More information about
BW LPG can be found at https://www.bwlpg.com.
BW LPG is associated with BW Group, a leading global maritime company involved
in shipping, floating infrastructure, deepwater oil & gas production, and new
sustainable technologies. Founded in 1955 by Sir YK Pao, BW controls a fleet of
over 450 vessels transporting oil, gas and dry commodities, with its 200 LNG and
LPG ships constituting the largest gas fleet in the world. In the renewables
space, the group has investments in solar, wind, batteries, biofuels and water
treatment.
This information is subject to disclosure requirements pursuant to Section 5-12
of the Norwegian Securities Trading Act.